Infectious Diseases

The FDA has granted Emergency Use Authorization (EUA) of the JYNNEOS vaccine for pediatric patients <18 years who are at high risk of monkeypox infection.

Only one-fifth of parents in a recent survey indicated intentions of getting their child the vaccine within 3 months of eligibility.

White House ramps up efforts to fight outbreak.

Learn about the selected strains for this year’s flu season, flu vaccine recommendation changes, and newly licensed and forthcoming vaccine options.

As immunization rates fall in children, the American Academy of Pediatrics recommends a checkup with physicians.

Many students are returning to a regular schedule for the first time since 2020. How will they fare?

The American Academy of Pediatrics (AAP) recommends children aged 5 to 11 receive the BNT-162b2 vaccination.

Codes enable billing for lab tests, administering vaccines.

The decision comes following reports of 16,000 cases across 75 countries and territories around the world.

Purchase follows FDA recommendation to include Omicron component in boosters.

The pandemic has disrupted academic progress and children with learning disabilities in particular have been impacted. Here is what pediatricians should know to help support literacy and recognize dyslexia.

Verrica is complying with the FDA through 3 Complete Response Letters to achieve the first FDA-approved treatment of molluscum contagiosum.

In children 5-11 years old, 2 doses of the Pfizer-BioNTech COVID-19 vaccine were moderately effective against documented, symptomatic Omicron infection.

Patients with a history of infection who were also vaccinated had the strongest protection, the data showed.

Recently, the AAP announced the launch of a public health campaign to educate caregivers on the benefits of vaccinating all ages.

The stress of enduring an infectious disease pandemic expresses itself in a variety of mental health conditions, but the likelihood of experiencing particular symptoms depends on who you are.

Data from Morbidity and Mortality Weekly Report showed that there was no demonstrated increase in pediatric hepatitis or adenovirus 40/41 above pre-COVID-19 pandemic baseline levels.

The FDA today announces the EUA of both Moderna and Pfizer-BioNTech COVID-19 vaccines for use in children aged 6 months and older.

AMA has adopted a multi-prong strategy to try to counter lies while holding the person responsible to professional review.

The US Food and Drug Administration (FDA) Vaccines and Related Biological Products Advisory Committee unanimously voted recently to recommend both the Pfizer-BioNTech and Moderna COVID-19 vaccines for individuals aged 6 months and older.

COVID-19 vaccination during pregnancy may reduce infants’ risk of infection during the early months of life, according to a recent study.

In a video for Contemporary Pediatrics®, Tina Tan, MD, FAAP, FIDSA, FPIDS, discusses an expansion of vaccine access likely to come with the FDA approval of the PRIORIX vaccine.

Kenneth J. Tomecki, MD, discussed the clinical relevance of sexually transmitted diseases to dermatology and outlined what to look for and how to treat various conditions at the 2022 Fall Clinical Dermatology Conference for PAs & NPs.

GSK plc today announced FDA approval of the PRIORIX vaccine for prevention of measles, mumps, and rubella.

Most children outgrow an adverse drug reaction to oral antibiotics, according to an Icelandic study.

A survey saw that of teenagers who sought care in the ED and were prescribed outpatient treatment, fewer than half who received an STI diagnosis filled their prescriptions.

Paul A. Offit, MD, pulls back the curtain on medical discoveries in "You Bet Your Life: From Blood Transfusions to Mass Vaccination, the Long and Risky History of Medical Innovation"

Study links inappropriate, off-guideline antibiotics to increased, avoidable allergic and adverse events in children.

Decreasing cases of chlamydia may offer false hope in light of decreased screening.

A look at what the Contemporary Pediatrics® team covered this week.